(1)
INVESTIGATIONS ON CLINICAL VALIDATION OF MUTATED ZNF208 AS A NOVEL BIOMARKER OF BLAST CRISIS IN CHRONIC MYELOID LEUKEMIA. J Popl Ther Clin Pharmacol 2024, 31 (9), 1502-1518. https://doi.org/10.53555/68zhqm37.